{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:48:21Z","timestamp":1782920901773,"version":"3.54.5"},"reference-count":51,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Background: Intra-articular (IA) stem cell injection is an emerging treatment for knee osteoarthritis (KOA). Three principal cell sources\u2014adipose-derived mesenchymal stem cells (ADMSCs), bone marrow-derived MSCs (BMMSCs), and peripheral blood-derived stem cells (PBSCs)\u2014have been evaluated independently; however, a systematic review comprehensively comparing all three sources under unified eligibility criteria is absent from the literature. Methods: Systematic searches of MEDLINE, Embase, Cochrane CENTRAL, and Scopus were conducted from inception to December 2025, supplemented by manual reference screening and ClinicalTrials.gov. Eligible studies included randomized controlled trials (RCTs) and prospective comparative studies in adult KOA patients. Primary outcomes were pain (VAS\/NRS) and function (WOMAC, KOOS) at \u22653 months. Risk of bias was assessed using RoB 2 and ROBINS-I; evidence certainty was rated using GRADE. Results: Thirty-one studies (n = 1247; ADMSC: 14 studies, n = 612; BMMSC: 12 studies, n = 487; PBSC: 5 studies, n = 148) met inclusion criteria. Pooled standardized mean differences (SMDs) for 6-month pain showed significant reduction versus comparators for ADMSCs (SMD \u22121.23; 95% CI \u22121.61 to \u22120.85; I2 = 62%) and BMMSCs (SMD \u22121.09; 95% CI \u22121.55 to \u22120.63; I2 = 70%). PBSCs demonstrated significant within-group improvement but were too few for formal pooling. Because no trial compared cell sources head-to-head, these estimates reflect within-source efficacy versus each study\u2019s own comparator rather than comparative superiority between sources. Adverse events were mild and transient across all sources. GRADE certainty was moderate for ADMSCs, low for BMMSCs, and very low for PBSCs. Conclusions: IA injection of ADMSCs and BMMSCs provides pain reduction and functional improvement in KOA with point estimates reaching minimal clinically important difference thresholds, although the certainty of this evidence is only moderate (ADMSC) to low (BMMSC). PBSC evidence is insufficient for formal comparison. Adequately powered, three-arm head-to-head RCTs that share a common comparator and a core outcome set are needed to establish comparative efficacy. Because only indirect comparisons were possible, this review supports efficacy within each cell source but cannot establish the superiority of one source over another.<\/jats:p>","DOI":"10.3390\/bioengineering13070771","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:41:38Z","timestamp":1782909698000},"page":"771","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy and Safety of Intra-Articular Adipose-Derived, Bone Marrow-Derived, and Peripheral Blood-Derived Stem Cell Injections for Knee Osteoarthritis: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7279-4862","authenticated-orcid":false,"given":"Se Yeong","family":"Jeon","sequence":"first","affiliation":[{"name":"Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Busan Medical Center, Busan 47527, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-2148","authenticated-orcid":false,"given":"Dong Ha","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Aerospace Medical Center, Republic of Korea Air Force, Cheongju 28330, Republic of Korea"},{"name":"Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/art.41142","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A Tool for Assessing Risk of Bias in Non-randomised Studies of Interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e20776","DOI":"10.7717\/peerj.20776","article-title":"Comparative Efficacy of Different Doses of Mesenchymal Stem Cells Derived from Different Tissue Sources for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Xie","year":"2026","journal-title":"PeerJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12967-016-0998-2","article-title":"Intra-articular Injection of Two Different Doses of Autologous Bone Marrow Mesenchymal Stem Cells versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis","volume":"14","author":"Mora","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"09636897241303275","DOI":"10.1177\/09636897241303275","article-title":"Intra-articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial","volume":"34","author":"Lee","year":"2025","journal-title":"Cell Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5966\/sctm.2015-0245","article-title":"Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial","volume":"5","author":"Pers","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s00167-022-07101-4","article-title":"Micro-Fragmented Adipose Tissue (mFAT) Associated with Arthroscopic Debridement Provides Functional Improvement in Knee Osteoarthritis: A Randomized Controlled Trial","volume":"31","author":"Ulivi","year":"2023","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00590-025-04322-4","article-title":"Adipose- and Bone Marrow-Derived Stromal Cells Reduce Pain in Patients with Knee Osteoarthritis but Do Not Substantially Improve Knee Functionality: An Updated Systematic Review and Meta-analysis","volume":"35","author":"Hohmann","year":"2025","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhu, Y., and Fu, W. (2022). Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.956614"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5312\/wjo.v14.i1.23","article-title":"Comparative Effectiveness of Adipose-Derived Mesenchymal Stromal Cells in the Management of Knee Osteoarthritis: A Meta-Analysis","volume":"14","author":"Muthu","year":"2023","journal-title":"World J. Orthop."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13287-023-03359-8","article-title":"Cartilage Regeneration and Inflammation Modulation in Knee Osteoarthritis Following Injection of Allogeneic Adipose-Derived Mesenchymal Stromal Cells: A Phase II, Triple-Blinded, Placebo-Controlled, Randomized Trial","volume":"14","author":"Sadri","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Centeno, C.J., Al-Sayegh, H., Bashir, J., Goodyear, S., and Freeman, M.D. (2015). A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis. BMC Musculoskelet. Disord., 16.","DOI":"10.1186\/s12891-015-0714-z"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcyt.2024.10.008","article-title":"Delphi-driven Consensus Definition for Mesenchymal Stromal Cells and Clinical Reporting Guidelines for Mesenchymal Stromal Cell-Based Therapeutics","volume":"27","author":"Renesme","year":"2025","journal-title":"Cytotherapy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9460","DOI":"10.1038\/s41467-024-53826-w","article-title":"Classification of Distinct Tendinopathy Subtypes for Precision Therapeutics","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1302\/2046-3758.1411.BJR-2025-0259.R1","article-title":"Xuetongsu Attenuates Bone Destruction in Rheumatoid Arthritis by Suppressing the RANKL\/RANK\/NFATc1 Pathway to Inhibit Osteoclastogenesis and Bone Resorption","volume":"14","author":"Zheng","year":"2025","journal-title":"Bone Jt. Res."},{"key":"ref_19","unstructured":"GBD 2021 Osteoarthritis Collaborators (2023). Global, Regional, and National Burden of Osteoarthritis, 1990\u20132020 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol., 5, e508\u2013e522."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review","volume":"325","author":"Katz","year":"2021","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(20)32230-3","article-title":"Osteoarthritis in 2020 and Beyond: A Lancet Commission","volume":"396","author":"Hunter","year":"2020","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The Global Burden of Hip and Knee Osteoarthritis: Estimates from the Global Burden of Disease 2010 Study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.arthro.2012.12.008","article-title":"Articular Cartilage Regeneration with Autologous Peripheral Blood Stem Cells versus Hyaluronic Acid: A Randomized Controlled Trial","volume":"29","author":"Saw","year":"2013","journal-title":"Arthroscopy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8925132","DOI":"10.1155\/2017\/8925132","article-title":"Avoidance of Total Knee Arthroplasty in Early Osteoarthritis of the Knee with Intra-Articular Implantation of Autologous Activated Peripheral Blood Stem Cells versus Hyaluronic Acid: A Randomized Controlled Trial with Differential Effects of Growth Factor Addition","volume":"2017","author":"Turajane","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1671S","DOI":"10.1177\/19476035211049562","article-title":"Novel Use of Intra-articular Granulocyte Colony Stimulating Factor (hG-CSF) Combined with Activated Autologous Peripheral Blood Stem Cells Mobilized with Systemic hG-CSF: Safe and Efficient in Early Osteoarthritis","volume":"13","author":"Papadopoulos","year":"2021","journal-title":"Cartilage"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, Y.-R., Yan, X., Yuan, F.-Z., Ye, J., Xu, B.-B., Zhou, Z.-X., Mao, Z.-M., Guan, J., Song, Y.-F., and Sun, Z.-W. (2020). The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration In Vivo: A Review. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00404"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s43465-022-00809-y","article-title":"Mobilized Autologous Peripheral Blood Stem Cells Are Pluripotent, Safe, and Efficient in Osteoarthritis of the Knee","volume":"57","author":"Papadopoulos","year":"2023","journal-title":"Indian J. Orthop."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Alfaqeh, H.H., Idrus, R.B.H., Saim, A.B., and Nordin, A. (2025). Synergistic Effects of Natural Products and Mesenchymal Stem Cells in Osteoarthritis Treatment: A Narrative Review. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47060445"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/14712598.2019.1671970","article-title":"Stromal Vascular Fraction Technologies and Clinical Applications","volume":"19","author":"Andia","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcyt.2018.11.003","article-title":"Safety and Efficacy of Allogenic Placental Mesenchymal Stem Cells for Treating Knee Osteoarthritis: A Pilot Study","volume":"21","author":"Forogh","year":"2019","journal-title":"Cytotherapy"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Riggle, C., McLellan, M., Bohlen, H., and Wang, D. (2024). Complications of Stem Cell-Based Injections for Knee Osteoarthritis: A Systematic Review. HSS J., Epub ahead of printing.","DOI":"10.1177\/15563316241271058"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e62659","DOI":"10.2196\/62659","article-title":"Effectiveness of Stromal Vascular Fraction and Platelet-Rich Plasma in Patients with Knee Osteoarthritis: Protocol for a Phase 3, Prospective, Randomized, Controlled, Multicenter Study (SPOST Study)","volume":"14","author":"Schwitzguebel","year":"2025","journal-title":"JMIR Res. Protoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/GME.0000000000001966","article-title":"Knee Osteoarthritis in Midlife Women: Unique Considerations and Comprehensive Management","volume":"29","author":"Curry","year":"2022","journal-title":"Menopause"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1177\/03635465231179223","article-title":"Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"51","author":"Kim","year":"2023","journal-title":"Am. J. Sports Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100500","DOI":"10.1016\/j.ocarto.2024.100500","article-title":"Safety and Efficacy of an Allogeneic Adipose-Derived Mesenchymal Stem Cell Preparation in the Treatment of Knee Osteoarthritis: A Phase I\/IIa Randomised Controlled Trial","volume":"6","author":"Freitag","year":"2024","journal-title":"Osteoarthr. Cartil. Open"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/03635465211053893","article-title":"Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fraction: Are They Effective for Patients with Knee Osteoarthritis? A Systematic Review with Meta-analysis of Randomized Controlled Trials","volume":"51","author":"Kim","year":"2023","journal-title":"Am. J. Sports Med."},{"key":"ref_37","first-page":"e82713","article-title":"Autologous Versus Allogeneic Adipose-Derived Mesenchymal Stem Cell Therapy for Knee Osteoarthritis: A Systematic Review, Pairwise and Network Meta-Analysis of Randomized Controlled Trials","volume":"17","author":"Kasagga","year":"2025","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13287-024-04034-2","article-title":"Rapid-Acting Pain Relief in Knee Osteoarthritis: Autologous-Cultured Adipose-Derived Mesenchymal Stem Cells Outperform Stromal Vascular Fraction: A Systematic Review and Meta-Analysis","volume":"15","author":"Lee","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, H., Felthaus, O., and Prantl, L. (2025). Adipose Tissue-Derived Therapies for Osteoarthritis: Multifaceted Mechanisms and Clinical Prospects. Cells, 14.","DOI":"10.3390\/cells14090669"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s12015-025-10909-5","article-title":"Therapeutic Potential of Adipose Mesenchymal Stem Cells for Synovial Regeneration: From In-Vitro Studies to Clinical Applications","volume":"21","author":"Levinson","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Adam, A.O., Benea, H.R.C., Fotescu, H.M., Alcal\u00e1 Ruiz, M., Cimpean, G.C., Ciornei, V., Cernacovschi, A., Edves, A.R., and Crisan, M. (2024). Recent Trends in Adipose Tissue-Derived Injectable Therapies for Osteoarthritis: A Scoping Review of Animal Models. Medicina, 60.","DOI":"10.3390\/medicina60050707"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23259671241296555","DOI":"10.1177\/23259671241296555","article-title":"Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials","volume":"12","author":"Han","year":"2024","journal-title":"Orthop. J. Sports Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Park, D., Koh, H.S., Choi, Y.H., and Park, I. (2025). Bone Marrow Aspirate Concentrate for Knee Osteoarthritis: A Narrative Review of Clinical Efficacy and Future Directions. Medicina, 61.","DOI":"10.20944\/preprints202503.0139.v1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00167-022-07153-6","article-title":"Bone Marrow Aspirate Concentrate Quality Is Affected by Age and Harvest Site","volume":"31","author":"Cavallo","year":"2023","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/s41598-024-51410-2","article-title":"Intra-articular Injection of Bone Marrow Aspirate Concentrate (Mesenchymal Stem Cells) in KL Grade III and IV Knee Osteoarthritis: 4-Year Results of 37 Knees","volume":"14","author":"Pabinger","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s43465-024-01168-6","article-title":"Bone Marrow Aspirate Concentrate for Treatment of Primary Knee Osteoarthritis: A Prospective, Single-Center, Non-randomized Study with 2-Year Follow-Up","volume":"58","author":"Jeyaraman","year":"2024","journal-title":"Indian J. Orthop."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2325967119900958","DOI":"10.1177\/2325967119900958","article-title":"Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial","volume":"8","author":"Anz","year":"2020","journal-title":"Orthop. J. Sports Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Park, D., Choi, Y.H., Kang, S.H., Koh, H.S., and In, Y. (2023). Bone Marrow Aspirate Concentrate versus Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells for Combined Cartilage Regeneration Procedure in Patients Undergoing High Tibial Osteotomy: A Systematic Review and Meta-Analysis. Medicina, 59.","DOI":"10.3390\/medicina59030634"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, Z., Hu, Z., Niu, L., Xu, Y., and Qi, Y. (2025). Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis Based on Rat Model. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1588841"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00402-019-03140-8","article-title":"Intra-articular Injection of Mesenchymal Stem Cells for Clinical Outcomes and Cartilage Repair in Osteoarthritis of the Knee: A Meta-Analysis of Randomized Controlled Trials","volume":"139","author":"Kim","year":"2019","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s13770-021-00390-9","article-title":"Kartogenin Promotes the BMSCs Chondrogenic Differentiation in Osteoarthritis by Down-Regulation of miR-145-5p Targeting the Smad4 Pathway","volume":"18","author":"Liu","year":"2021","journal-title":"Tissue Eng. Regen. Med."}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/7\/771\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:13:20Z","timestamp":1782918800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/7\/771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["bioengineering13070771"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering13070771","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}